Abstract:Accumulative evidence has revealed that the histone deacetylase SIRT6 plays important roles in various cancers. However, the biological effect of SIRT6 on the progression of melanoma remains unclear. Given the pivotal role of autophagy in regulating melanoma progression and the fact that SIRT6 could inhibit the expression of the key autophagy modulator Akt, we therefore hypothesized that SIRT6 can have an impact on melanoma development through the regulation of autophagy. In the present study, we initially examined the expression levels of SIRT6 in both melanoma tissues and melanoma cell lines at different stages. We found that SIRT6 expression was significantly decreased in primary melanoma but increased in metastatic melanoma compared with that in melanocytic nevus, both in vitro and in vivo. We subsequently examined the level of autophagy in melanoma and intriguingly showed that the aberrant changes of SIRT6 expression and autophagy level are in highly parallel. Furthermore, functional study proved that SIRT6 could attenuate primary melanoma progression by promoting apoptosis and inhibiting proliferation, invasion and migration. And SIRT6 could conversely accentuate metastatic melanoma development through the inhibition of apoptosis and the enhancement of cell proliferation, invasion and migration. Moreover, we revealed that the paradoxical role of SIRT6 in melanoma development was played in an autophagy-dependent manner. In addition, we confirmed that SIRT6 could regulate autophagy by inhibiting Akt signaling. Finally, xenograft tumor model was adopted to testify the pivotal role of SIRT6 in melanoma in vivo. Taken together, our study demonstrated that the aberrant SIRT6 has a crucial suppressive or facilitative effect on melanoma development at different stages by regulating Akt signaling and autophagy.

SIRT6 suppresses colon cancer growth by inducing apoptosis and autophagy through transcriptionally down-regulating Survivin

SIRT6, a novel direct transcriptional target of FoxO3a, mediates colon cancer therapy

Sirtuin 6 inhibits colon cancer progression by modulating PTEN/AKT signaling

SIRT6 Promotes Autophagy Through Direct Interaction with ULK1 and Competitive Binding to PUMA

Overexpression of Sirt6 is a novel biomarker of malignant human colon carcinoma.

Decreased Expression of SIRT6 Promotes Tumor Cell Growth Correlates Closely with Poor Prognosis of Ovarian Cancer.

Sirtuin 6 is a Negative Regulator of the Anti-Tumor Function of Natural Killer Cells in Murine Inflammatory Colorectal Cancer

SIRT6 Inhibits Anoikis of Colorectal Cancer Cells by Down-Regulating NDRG1

Sirtuin SIRT6 Suppresses Cell Proliferation Through Inhibition of Twist1 Expression in Non-Small Cell Lung Cancer.

SIRT6 Promotes the Progression of Prostate Cancer via Regulating the Wnt/β-Catenin Signaling Pathway

Inhibition of Sirt6 in Prostate Cancer Reduces Cell Viability and Increases Sensitivity to Chemotherapeutics

632 Aberrant Expression of SIRT6 Contributes to the Development of Melanoma by Regulating Autophagy

The Histone Deacetylase SIRT6 Inhibits Ovarian Cancer Cell Proliferation Via Down-Regulation of Notch 3 Expression.

Function of SIRT6 in tumor initiation and progression

Survivin Stable Knockdown by Sirna Inhibits Tumor Cell Growth and Angiogenesis in Breast and Cervical Cancers

Mammalian SIRT6 Represses Invasive Cancer Cell Phenotypes through ATP Citrate Lyase (ACLY)-Dependent Histone Acetylation

SIRT6 Abrogation Promotes Adrenocortical Carcinoma Through Activation of NF-κB Signaling

Inhibition of the overexpressing SIRT6 sensitizes prostate cancer cells to chemotherapeutics

SIRT6 Overexpression Induces Massive Apoptosis in Cancer Cells but Not in Normal Cells

Induced Epigenetic Modifications of the Promoter Chromatin Silence Survivin and Inhibit Tumor Growth.

Regulation of survivin by PI3K/Akt/p70S6K1 pathway.